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Abstract
Purpose Articular resurfacing by treatment of chondral
defects may include chondral abrasion, autologous chon-
drocyte Implantation (ACI), matrix-induced chondrocyte
transplantation (MACT) or osteochondral autologous
transplantation (OATS). This technical note describes the
method of autologous matrix-induced chondrogenesis
(AMIC), a one-step procedure combining subchondral
microfracture with the fixation of a collagen I/III mem-
brane with fibrin glue or sutures.
Methods This is a technical note on the AMIC procedure
and its further development.
Results and conclusion This method is applied primarily
in chondral or osteochondral lesions of the knee. Indica-
tions and contraindications are provided; the technique is
described. The further development of AMIC is described
with an increased focus on the subchondral zone and the
complex of cartilage and bone, the osteochondral unit,
which receives increased attention in cartilage research.
Level of evidence IV.
Keywords Chondral defects  Osteochondral defects 
AMIC  Microfracturing
Introduction
Chondral or osteochondral defects are of particular interest
for the orthopaedic surgeon as these normally do not
heal spontaneously. During the past 20 years regenerative
techniques applying collagen membranes on treated carti-
lage defects were developed. It was demonstrated that these
collagen II membranes facilitate differentiation of MSCs
into chondrocytes whilst providing a scaffold for the
chondrocytes to form cartilage [14, 21]. Fixation of the
scaffold with commercially available fibrin glue seems to
be advantageous as fibrin glue seems to act as an additional
scaffold for chondrocytes and that its contents in TGF b are
considerable, possibly helping in differentiation of mes-
enchymal stem cells [14].
The cartilage resurfacing procedures most frequently
applied are as follows: abrasion arthroplasty and
debridement [7, 12], the autologous chondrocyte implan-
tation (ACI) as introduced by Brittberg [8, 9, 16, 18], the
method of microfracturing as developed by Steadmann
[22, 23] and the osteochondral autologous transplantation
system (OATS) [6].The ACI involves a two-step proce-
dure transplanting chondrocytes previously taken from a
donor site into a cartilage defect [8, 9]. In microfractur-
ing, the calcified subchondral bone/cartilage border is
perforated, consecutively fibrous cartilage is developed
from mesenchymal stem cells [22, 23]. OATS means
taking autologous osteochondral grafts from a non-weight
bearing joint site and transplanting them to the defect
[2, 6, 11].
The matrix associated chondrocyte transplantation
(MACT) is a further development in cartilage resurfacing
which allows previously harvested chondrocytes to differ-
entiate into chondrocytes with the aid of a collagen scaffold
[1, 3].
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The autologous matrix-induced chondrogenesis (AMIC)
as first introduced by Behrens et al. [4, 13] further develops
the matrix/scaffold technique in combination with micro-
fracturing. It is a less-expensive one-step procedure which
combines microfracturing of the cartilage/bone-lamina
after debridement of the cartilage lesion with fixation of a
commercially available porcine collagen I/III matrix. This
matrix covers the blood clot and its mesenchymal stem
cells (MSCs) whilst permitting the MSCs to develop into
chondrocytes [4, 13, 14, 19].
The objective of this technical note is to demonstrate the
AMIC technique in its original form and its further
development and to compare its results with the literature.
Technical note
Indications for AMIC are symptomatic full thickness
(ICRS grade 4) lesions and osteochondral lesions such as in
osteochondrosis dissecans. The lesion should not exceed
1.5 cm2, and the location should normally be in the weight
bearing region, bearing the highest risk for degenerative
joint disease. Contraindications are kissing or multiple
lesions, inflammatory diseases such as rheumatoid arthritis,
tumour, an uncorrected ligamentous balancing or lesions of
the cruciate and collateral ligaments, extension deficit of
more than 10, flexion deficits of more than 100, mala-
lignment and associated fractures. If an osteochondral
defect is present, the author’s preferred method is the
closure of the osseous defect with an autologous bone
transplant from the tibial head which may be harvested
during the same procedure. The cancellous bone is
impacted into the defect, and the membrane is attached on
the defect with either fibrin glue or sutures.
The procedure starts with an arthroscopy of the affected
joint to verify the size and location of the defect and also
the amount of accompanying disorder. After determining
the size and location and after a diagnostic arthroscopy
ruling out accompanying lesions or ligamentous problems,
an AMIC procedure may be initiated. A minimally invasive
arthrotomy is performed and the defect is visualized
openly. The defective cartilage tissue and subchondral
bone is removed with a curette (Fig. 1a).
If an osteochondral lesion is present, cancellous bone
may be harvested from the tibial head using the same
incision. An aluminium template may be used to determine
the size of the lesion and the appropriate membrane
(Fig. 1b).
Membrane and template should be slightly undersized to
avoid dislocation after movement. Microfracturing used to
be performed in the original method described by Behrens
et al. [4, 13] with the corresponding microfracturing awls.
We have further developed the perforation of the
subchondral zone according to the latest literature studies
which seem to demonstrate that the subchondral stroma is
better reached by drilling [10, 16]. A 1.1 mm K-wire is
now drilled either by hand or by machine with constant
cooling being applied so the subchondral bone is reached
(Figs. 2, 3a).
A partially autologous fibrin glue may be manufactured
by centrifuging a blood sample from the patient and mixing
the yielded thrombin with allogenic fibrinogen from com-
mercially available fibrin glue. Commercially available
allogenic fibrin glue or suturing for fixation may also be
applied (Fig. 3b).
Suturing, however, may lead to cartilage damage [3].
Knecht et al. [17] have confirmed that glueing with fibrin
Fig. 1 Curettage of the defect and measuring of an aluminium
template
Fig. 2 Microfracturing should be performed with a 1.1 mm K-wire
which is the author’s preferred method of treatment. Cooling with
sterile NaCl solution is advisable. Drilling seems to reach the
subchondral bone better than microfracturing alone
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glue leads to sufficient stability of a collagen membrane. It
is important that the collagen membrane is placed slightly
below the cartilage level because displacement after
moving the joint is almost certain if the membrane stays
above the cartilage rim. (Fig. 3c).
The joint should be gently moved intra-operatively.
Inspection of the site is advisable and should confirm that
the membrane remains in place.
The postoperative management is as follows: maximum
weight bearing 15–20 kg for 6 weeks, common thrombose
prophylaxis with a low molecular heparin, and continuous
joint movement. Removal of a possible drain 24 h after
surgery is recommended. Care should be exercised that the
suction is removed as this could lead to membrane
dislocation.
Maximum flexion of the knee should not exceed 30 for
2 weeks following the operation. Flexion is raised to 60
and 90 for another 2 weeks, respectively. The patient is
seen in the outpatient clinic 6 weeks after the appointment.
Discussion
The most important feature of the present technical note is
the introduction of a combined microfracturing and colla-
gen method for cartilage surgery which is further developed
according to the latest findings in cartilage physiology.
Chondral or osteochondral injuries affect a broad spec-
trum of patients with knee pain. They may be either
posttraumatic or with an unknown cause such as osteo-
chondrosis dissecans. Young active adults may be
involved. These defects may eventually lead to progressive
joint destruction by osteoarthritis, thus gaining significant
interest by the orthopaedic surgeon to develop proper
treatment. However, as many studies treat this subject, no
procedure may be recommended as the treatment of choice
at this time [5].
Gille et al. [13] reported good mid-term results of AMIC
reporting that 87% of the treated patients were highly
satisfied with the result. This compares well with the results
after microfracturing alone [20, 22, 23].
Drilling does not seem to have such a deleterious effect
on the subchondral bone matrix as was once expected but
instead leads to better access to the bone-marrow stroma in
the rabbit model [10]. A study of de Girolamo et al. [15]
suggests a difference in mesenchymal stem cells (MSCs)
harvested after microfracturing and primarily from the iliac
crest. It is suggested that the MSCs from the microfractured
areas demonstrate a different and comparatively irregular
pattern than those harvested from the iliac crest.
Following these new findings in cartilage surgery
research, the authors have, therefore, modified the original
AMIC method and switched from conventional micro-
fracturing awls to drilling with K wires. It seems to become
increasingly important to include the osteochondral unit
into cartilage surgery rather than focus on the cartilage
alone as this is likely a complex system including inter-
action between bone and cartilage [16].
The AMIC procedure was developed as a one-step
procedure that may be cost-effective and qualify for
reimbursement by the health insurances. It has the advan-
tage of a one-step procedure that combines microfracturing
with chondrocyte differentiation from MSCs on a collagen
matrix. The initially formed blood clot as produced by
microfracturing is protected by the collagen membrane.
However, since this is a new method, it has yet to show its
advantages over microfracturing or simple de´bridement
alone. A disadvantage which may be minimized by mini-
mally invasive methods is the open procedure. Prospective
randomized studies should be implemented investigating
this method, especially in comparison with microfracturing
alone.
The AMIC procedure may be a cost-effective option for
the surgeon treating cartilage defects. It is easy to apply,
and it supplies the cartilage surgeon with a procedure to
offer a patient with a symptomatic cartilage defect.
Conclusion
Combining micro-fracturing with a collagen I/III scaffold
may be a cost-effective option for articular resurfacing by
Fig. 3 a–c After microfracturing of the defect, fibrin glue is applied and the collagen II membrane attached. From Gille et al.: Mid-term results
of autologous matrix-induced chondrogenesis for treatment of focal cartilage effects in the knee, Knee Surg Sports Traumatol Arthrosc 2010
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treating chondral or osteochondral defects. More prospec-
tive randomized Level of Evidence 1 and 2 studies should
compare the results of the AMIC procedure as compared to
micro-fracturing alone and MACI, both related to AMIC
but more cost intensive. Drilling the subchondral zone and
reaching the bone-marrow stroma may be more effective
than microfracturing with an awl alone.
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